Company Analysis Coloplast A/S
1. Summary
Advantages
- Price (8.48 $) is less than fair price (10.14 $)
- Dividends (3.17%) are higher than the sector average (1.7%).
- The stock's return over the last year (-18.04%) is higher than the sector average (-36.22%).
- The company's current efficiency (ROE=28.67%) is higher than the sector average (ROE=14.51%)
Disadvantages
- Current debt level 47.07% has increased over 5 years from 8.37%.
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Coloplast A/S | Healthcare | Index | |
|---|---|---|---|
| 7 days | -0.8% | -44.5% | 0.4% |
| 90 days | -9.9% | -43.1% | 3.6% |
| 1 year | -18% | -36.2% | 15.6% |
CLPBY vs Sector: Coloplast A/S has outperformed the "Healthcare" sector by 18.19% over the past year.
CLPBY vs Market: Coloplast A/S has significantly underperformed the market by -33.61% over the past year.
Stable price: CLPBY is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: CLPBY with weekly volatility of -0.3468% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Below fair price: The current price (8.48 $) is lower than the fair price (10.14 $).
Price not significantly lower than the fair price: The current price (8.48 $) is slightly lower than the fair price by 19.6%.
5.2. P/E
P/E vs Sector: The company's P/E (39.04) is lower than that of the sector as a whole (45.46).
P/E vs Market: The company's P/E (39.04) is lower than that of the market as a whole (45.03).
5.2.1 P/E Similar companies
5.3. P/BV
P/BV vs Sector: The company's P/BV (10.99) is higher than that of the sector as a whole (5.31).
P/BV vs Market: The company's P/BV (10.99) is higher than that of the market as a whole (4.36).
5.3.1 P/BV Similar companies
5.5. P/S
P/S vs Sector: The company's P/S indicator (7.3) is higher than that of the sector as a whole (4.3).
P/S vs Market: The company's P/S indicator (7.3) is lower than that of the market as a whole (12.87).
5.5.1 P/S Similar companies
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (25.83) is higher than that of the sector as a whole (17.43).
EV/Ebitda vs Market: The company's EV/Ebitda (25.83) is higher than that of the market as a whole (23.89).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Rising and has grown by 4.07% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (4.07%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-1.46%).
6.4. ROE
ROE vs Sector: The company's ROE (28.67%) is higher than that of the sector as a whole (14.51%).
ROE vs Market: The company's ROE (28.67%) is lower than that of the market as a whole (50.88%).
6.6. ROA
ROA vs Sector: The company's ROA (10.5%) is higher than that of the sector as a whole (7.45%).
ROA vs Market: The company's ROA (10.5%) is lower than that of the market as a whole (35.83%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (24.19%) is higher than that of the sector as a whole (14.14%).
ROIC vs Market: The company's ROIC (24.19%) is higher than that of the market as a whole (10.8%).
8. Dividends
8.1. Dividend yield vs Market
High yield: The dividend yield of the company 3.17% is higher than the average for the sector '1.7%.
8.2. Stability and increase in payments
Dividend stability: The company's dividend yield 3.17% has been steadily paid over the past 7 years, DSI=0.93.
Weak dividend growth: The company's dividend yield 3.17% has been growing weakly or stagnant over the past 5 years. Growth over only 3 years.
8.3. Payout percentage
Dividend Coverage: Current payments from income (93.43%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
Based on sources: porti.ru
